TOLL FREE: 888.88.INFECT
PHONE: 517.536.8210
FAX: 517.536.8205

THE WELLHOFF CENTER
7190 S. BROOKLYN RD.
JACKSON, MI 49201

TransPharm Preclinical Solutions TransPharm Preclinical Solutions TransPharm Preclinical Solutions TransPharm Preclinical Solutions

Posts by TPPS

February 2017

A Note from the President January 2017 marked our 9 year anniversary and the close of another great year here at TransPharm. With 17 new clients in 2016, the TransPharm family now spans over 6 continents. As a result of our continued growth, we were able to reach a major milestone in November: a total of $10M in revenue since I founded the company in 2008. Increased demand also allowed us to welcome some new faces to our team – Brianne Fiero (Associate Scientist) in April, and Brittany Dixon (Scientific Writer) and Emily Gilles (Laboratory Technician) in October. 2016 was also a year of physical growth. A 2,100 sq. ft. addition to our facility, including an expanded animal vivarium and a procedure room, was completed in May. This new space contains both a negative pressure room and a positive pressure room, with corresponding bioBUBBLE® enclosures in each, meaning separate, dedicated areas for C. difficile and germ-free work, respectively. The renovations have already proven advantageous to our clients who currently work in the C. difficile therapy development field. Please contact us for more information. Finally, I’d like to extend an open invitation to visit us here at TransPharm. We wouldn’t be celebrating these successes without our clients, and we’d love the opportunity to meet you personally and provide a tour of our facilities. Thank you for your business and we look forward to working with you in the new year. Daniel Ross President & CEO TransPharm Preclinical Solutions                   In the Lab This past summer, six local high school and college students interested in a career in life science participated in TransPharm’s internship program. Each student spent two weeks working on their own model validation project focused on one of the ESKAPE pathogens. These bacteria, listed below, cause the majority of US hospital infections and are increasingly resistant to current antimicrobials.   Enterococcus faecium Staphylococcus aureus Klebsiella pnuemonia Acinetobacter baumannii Pseudomonas aeruginosa Enterobacter species   Thanks to the hard work of these motivated students and historical data, TransPharm now has a validated model for all ESKAPE pathogens, with some pathogens having several models available. Contact us today for quotes or more information....

Read More